Epstein Secrets

Exhibit 0: Option Pricing Method Analysis Exhibit P: Adjustment for Lack of Marketability William L Silber Study Management Planning, Inc. Study FMV Study Selected Marketability Discount Exhibit Q: Put Option Analysis Appendices Appendix 1: Guideline Company Tear Sheets Appendix 2: Studies Regardin

asted revenues and expenses highlighted above and was detanitheil hi he reawnable bawd on guideline company indications. According to management. the Company\ , term EBIT margin is expected to be higher than the average and median of the guideline company indications as a result of the anticipated increas

Exhibit 0: Option Pricing Method Analysis Exhibit P: Adjustment for Lack of Marketability William L Silber Study Management Planning, Inc. Study FMV Study Selected Marketability Discount Exhibit Q: Put Option Analysis Appendices Appendix 1: Guideline Company Tear Sheets Appendix 2: Studies Regardin

asted revenues and expenses highlighted above and was detanitheil hi he reawnable bawd on guideline company indications. According to management. the Company\ , term EBIT margin is expected to be higher than the average and median of the guideline company indications as a result of the anticipated increas

Exhibit 0: Option Pricing Method Analysis Exhibit P: Adjustment for Lack of Marketability William L Silber Study Management Planning, Inc. Study FMV Study Selected Marketability Discount Exhibit Q: Put Option Analysis Appendices Appendix 1: Guideline Company Tear Sheets Appendix 2: Studies Regardin

asted revenues and expenses highlighted above and was detanitheil hi he reawnable bawd on guideline company indications. According to management. the Company\ , term EBIT margin is expected to be higher than the average and median of the guideline company indications as a result of the anticipated increas